- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03315728
Pathways for Health Equity Quality Improvement Strategy
Transformation of Indigenous Primary Healthcare Delivery: Enhancement and Adaptation of Community-driven Innovations and Scale-up Toolkits
The PATHWAYS for Health Equity research program builds on the 5-year FORGE AHEAD Indigenous diabetes quality improvement research program (2013 - 2017).
PATHWAYS for Health Equity, a 3-year research program (2017 - 2019), is a great opportunity to continue our important collaborative diabetes quality improvement research with an increasing number of Indigenous partnering communities and researchers and key stakeholders (collaborators, policymakers and knowledge-users). Four partnering First Nations communities will join the Pathways program to develop community-driven quality improvement initiatives championed by a Community Facilitator and supported by a Community Data Coordinator.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
GOAL
To improve the health and health equity of Indigenous peoples by strengthening the effectiveness, sustainability and scalability of a promising community-driven and culturally-relevant quality improvement strategy through meaningful conversations and engagement with our community partners.
OBJECTIVES
- Engage community partners and key stakeholders to support meaningful participation and leadership
- Review, improve and adapt the diabetes quality improvement strategy with community partners
- Evaluate the effectiveness of the adapted diabetes quality improvement strategy
- Develop community-driven plans for sustainability and scale-up for the adapted diabetes quality improvement strategy
WHY IS PATHWAYS IMPORTANT?
In Canada, there are significant inequalities between the health status of Indigenous peoples and the general population concerning diabetes. Community-driven initiatives using promising diabetes quality improvement strategies can potentially reform local healthcare in Indigenous communities and improve care for those living with diabetes.
WHAT IS INVOLVED IN PATHWAYS?
Community-based champions called Community Facilitators and Community Data Coordinators will be trained to provide leadership and support to community-based teams to make priority improvements to diabetes programs/ services and clinical care. The 18-month quality improvement intervention includes:
- educational workshops on diabetes and quality improvement
- support, communication, and coaching for action planning and quality improvement
- readiness consultation tools
- diabetes registry & surveillance system
An evaluation consisting of interviews and questionnaires may be used to understand the process of adapting the diabetes quality improvement strategy to each community's context and factors that influence the program's success.
Our strong, multidisciplinary and cross-jurisdictional PATHWAYS Team includes Indigenous community representatives and healthcare providers, nonIndigenous healthcare providers, clinician scientists and academic researchers, as well as policy decision-makers and knowledge-user organizations.
The timely program will provide community leaders and knowledge-users with policy recommendations and a quality improvement strategy that can be implemented, sustained and spread to Indigenous community settings and regions across Canada and internationally.
COMMUNITY PARTNERS
Four community partners will be engaged and will partner in the Pathways program (two in Ontario and two in Atlantic Canada). Formal Community Research Agreements will represent participation and partnership.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6C 4Z9
- Western University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Indigenous Communities in Canada:
- On-reserve community
- Community Band Council approval to participate and collaboration
- Community healthcare facility approval or willingness to participate including both prevention and management/treatment arms if separate
- Signed Community Research Agreement (including Financial Agreement) by the custodian of community medical charts, health leadership, and community leadership (if required). Access to community medical charts is required for FNDSS
Patient Chart Inclusion Criteria for chart audit component:
- Age 18 or older.
- Diagnosed with type 2 diabetes
Exclusion Criteria:
Indigenous Communities:
- Communities that are unlikely to comply with the protocol (uncooperative attitude, unlikelihood of completing the program)
- Healthcare facility unwilling to participate or uncooperative.
Patient Chart Exclusion Criteria for chart audit component:
- Less than 18 years old
- Diagnosed with type 1 or gestational diabetes
- Life expectancy is less than 6 months
- Inactive patient (no clinic visit in the last 12 months)
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Quality Improvement Strategy
First Nations communities partners are a diverse group of Indigenous communities reflecting wide variation in contextual factors: healthcare delivery and funding models; population size; remoteness; governance structures; and access to primary, secondary and tertiary care.
Four diverse communities will partner in the program (two in Ontario and two in Atlantic Canada).
All four communities will undertake an 18- month Quality Improvement Strategy intervention where they develop community-driven and culturally-relevant initiatives to improve diabetes care and management in their community
|
Quality improvement strategy The 18 month Quality Improvement Strategy includes 3 months preparation, 12 months intervention, 3 months local knowledge translation.
The intervention includes Readiness Consultations to assist in understanding available resources to address and adopt diabetes and chronic disease prevention and care strategies.
Community teams receive a series of 3 workshops (in-person/virtual) followed by action periods where the team carry out and evaluate PDSAs they develop to improve diabetes care.
Coaching is provided by Western during the 3-4 month action periods.
FNDSS is a webbased secure community portal system for communities to develop a diabetes registry/surveillance system and generate reports and plan QI initiatives.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Understand the influence of community context on the implementation of the QI Strategy as assessed by the Consolidated Framework for Implementation Research
Time Frame: November 2017 - April 2019
|
Qualitative information will be collected by interviews or focus groups to understand how context influences the implementation of the QI strategy.
Questions on the interview are guided by the Consolidated Framework for Implementation Research, which includes questions on intervention characteristics, outer community setting, inner community setting, characteristics of individuals/teams, and implementation processes.
|
November 2017 - April 2019
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated hemoglobin (A1C)
Time Frame: November 2017 - April 2019
|
Improvement in A1C will be assessed using the community's FNDSS portal.
|
November 2017 - April 2019
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stewart Harris, MD, Western University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R2722A59
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus Type 2 With Hyperglycemia
-
Charles Drew University of Medicine and ScienceTerminatedDiabetes Mellitus Type 2 With HyperglycemiaUnited States
-
BloomedInInstitut universitaire de cardiologie et de pneumologie de Québec, University...Active, not recruitingInflammation | Hypertension | Dysbiosis | Diabetes Mellitus Type 2 in Obese | Diabetes Mellitus Type 2 With HyperglycemiaCanada
-
Mahidol UniversityUnknownPeriodontitis | Diabetes Mellitus Type 2 With HyperglycemiaThailand
-
Johns Hopkins UniversityCompletedType 2 Diabetes | Hyperglycemia Due to Type 2 Diabetes MellitusUnited States
-
Yale UniversityTerminatedDiabetes Mellitus Type 2 | Stress HyperglycemiaUnited States
-
Karolinska InstitutetCompletedType 2 Diabetes Mellitus | Postprandial HyperglycemiaSweden
-
Universitas Muhammadiyah SurakartaNot yet recruitingHyperglycemia | Type 2 Diabetes Mellitus (T2DM)
-
Instytut Diabetologii Sp. z o.o.National Center for Research and Development, Poland; Nalecz Institute of Biocybernetics...UnknownType 1 Diabetes Mellitus With Hyperglycemia | Type 1 Diabetes Mellitus With HypoglycaemiaPoland
-
Thymia LimitedCompletedType 2 Diabetes | Diabetes (DM) | T2DM (Type 2 Diabetes Mellitus) | T2DMUnited Kingdom
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
Clinical Trials on Quality Improvement Strategy
-
University of MinnesotaColon and Rectal Surgery Associates, Ltd.CompletedColorectal Surgery | Colectomy | IleostomyUnited States
-
Institute for Clinical Effectiveness and Health...Inter-American Development BankUnknownColorectal NeoplasmsArgentina
-
Institute for Clinical Effectiveness and Health...Ministry of Public Health, ArgentinaCompletedCardiovascular Diseases | Quality ImprovementArgentina
-
Brigham and Women's HospitalCompletedGestational Diabetes Mellitus
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...Completed
-
Duke UniversityNorthwestern University; Wake Forest University Health SciencesCompletedSickle Cell DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterConcord Hospital; MGH Multiple Sclerosis Clinic; University of Vermont Multiple... and other collaboratorsCompletedMultiple SclerosisUnited States
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); AstraZeneca; Canadian Diabetes... and other collaboratorsCompletedType 2 Diabetes MellitusCanada
-
HealthPartners InstituteNovartis; TriHealth Inc.; William Beaumont Hospitals; Advocate Medical Group; Baystate... and other collaboratorsCompleted